12:00 AM
 | 
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ferrer, Vivia Biotech deal

The companies partnered to co-develop Vivia009 to treat blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Vivia...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >